Department of Chemistry, Wake Forest University, Winston Salem, NC 27109, USA.
J Fluoresc. 2012 Jan;22(1):247-52. doi: 10.1007/s10895-011-0954-8. Epub 2011 Aug 19.
A simple, selective and sensitive luminescence method has been developed for the assay of etodolac (I), moxepril HCl (II) and fexofenadine HCl (III) in bulk drug and pharmaceutical formulations. The method is based on the luminescence sensitization of europium (Eu(3+)) by complexation with the studied drugs. The fluorescence intensities of the products were measured at 667 nm for (I) and at 615 for (II) and (III) while exciting at 276 for all the studied drugs. The fluorescence intensity was directly proportional to the concentration over the range (20-280), (40-240) and (30-80) ng/ml with limits of detection (LOD) = 0.93, 0.92 and 0.95 μg/ml for drugs I, II and III respectively. Optimum conditions for the formation of the complex in methanol were carefully studied. The proposed method was successfully applied for the assay of the studied drugs in pharmaceutical formulations with excellent recovery.
一种简单、选择性和灵敏的荧光法已被开发用于测定原料药和药物制剂中的依托度酸(I)、莫昔普利盐酸盐(II)和盐酸非索非那定(III)。该方法基于药物与铕(Eu(3+))络合后对 Eu(3+)的荧光增敏作用。产物的荧光强度在 667nm 处测定(I),在 615nm 处测定(II)和(III),同时在所有研究药物中激发波长为 276nm。荧光强度与浓度在(20-280)、(40-240)和(30-80)ng/ml 范围内呈直接比例关系,对于药物 I、II 和 III,检测限(LOD)分别为 0.93、0.92 和 0.95μg/ml。仔细研究了甲醇中形成配合物的最佳条件。该方法成功地应用于药物制剂中研究药物的测定,具有良好的回收率。